US EditionPublished • loading... • Updated
New Guideline Puts Some at the Front of the Line for GLP-1, SGLT2 Drugs
Summary by MedPage Today
2 Articles
2 Articles
MedPage TodayReposted by 
Anti-Aging, Acupuncture and Health News
Anti-Aging, Acupuncture and Health NewsNew Guideline Puts Some at the Front of the Line for GLP-1, SGLT2 Drugs
(MedPage Today) -- No blanket recommendation can be made for SGLT2 inhibitors and GLP-1 receptor agonists in adults with type 2 diabetes (T2D) without considering cardiovascular and kidney risks, according to a BMJ panel. In a new "living" guideline...
·New York, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
